SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-04-002525
Filing Date
2004-01-30
Accepted
2004-01-30 12:17:39
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2126544z20-f.htm 20-F 2506066
3 EX-1.1 a2126544zex-1_1.htm EX-1.1 63666
4 EXHIBIT 1.2 a2126544zex-1_2.htm EX-1.2 89827
5 EXHIBIT 4.3 a2126544zex-4_3.htm EX-4.3 35753
6 EXHIBIT 12.1 a2126544zex-12_1.htm EX-12.1 5937
7 EXHIBIT 12.2 a2126544zex-12_2.htm EX-12.2 5662
8 EXHIBIT 13 a2126544zex-13.htm EX-13 4302
9 EX-14.1 a2126544zex-14_1.htm EX-14.1 2364
10 G903347.JPG g903347.jpg GRAPHIC 8371
  Complete submission text file 0001047469-04-002525.txt   2724267
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 04554864
SIC: 2834 Pharmaceutical Preparations